Elisavet Paplomata

Elisavet Paplomata

University of Wisconsin Madison - Madison / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1832008
person_outline Elisavet Paplomata's MOST POPULAR ARTICLES
1-) Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancerRK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ...New England Journal of Medicine 382 (7), 597-609, 20207052020
2-) The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkersE Paplomata, R O’ReganTherapeutic advances in medical oncology 6 (4), 154-166, 20144122014
3-) Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trialNU Lin, V Borges, C Anders, RK Murthy, E Paplomata, E Hamilton, ...Journal of Clinical Oncology 38 (23), 2610, 20202552020
4-) Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer …M Radovich, G Jiang, BA Hancock, C Chitambar, R Nanda, C Falkson, ...JAMA oncology 6 (9), 1410-1415, 20202282020
5-) Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final …G Curigliano, V Mueller, V Borges, E Hamilton, S Hurvitz, S Loi, R Murthy, ...Annals of Oncology 33 (3), 321-329, 20221662022